Adjuvant Therapy Versus Endoscopic Surgery Alone in Early-stage Recurrent Nasopharyngeal Carcinoma: A Multicenter Randomized Controlled Trial
Adjuvant Therapy Versus Endoscopic Surgery Alone in Early-stage Recurrent Nasopharyngeal Carcinoma: A Multicenter Randomized Controlled Trial
• Pathologically diagnosed with recurrent nasopharyngeal carcinoma;
• Stage rT1 or rT2(superficial parapharyngeal space, distance to internal carotid artery \>5mm)or rT3 (confined to the bottom wall of the sphenoid sinus),according to AJCC 8th edition;
• Cervical lymph node metastasis can be controlled locally
• Age 18 to 75 years;
• Without distant metastasis;
• Informed consent forms signed;
• ≥6months from the accomplishment of radiation to recurrence
• previously radiotherapy for only 1 course;
• ECOG score 0-2 and can tolerate chemotherapy and immunotherapy
⁃ Sufficient organ function;
⁃ Undergone endoscopic surgery with negative pathological margin;